[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337513-105":59,"doc-detail-337513-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"zh","research-progress-of-granulocytic-myeloid-derived-suppressor-cells-in-non-small-cell-lung-cancer","粒细胞样髓源性抑制细胞在非小细胞肺癌中的研究进展","","粒细胞样髓源性抑制细胞（G-MDSCs）是髓源性抑制细胞的重要亚群，广泛富集于多种肿瘤，通过表达精氨酸酶I（Arg-1）及活性氧（ROS）等机制抑制淋巴T细胞杀伤功能，重塑肿瘤免疫微环境并促进肿瘤发生发展。近年来研究提示，G-MDSCs与非小细胞肺癌患者预后及免疫治疗疗效显著相关。靶向其募集、分化与功能的药物有望抑制肿瘤进展，本文对相关免疫抑制作用及通路靶向药物进展进行综述。",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/research-progress-of-granulocytic-myeloid-derived-suppressor-cells-in-non-small-cell-lung-cancer/337513/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/research-progress-of-granulocytic-myeloid-derived-suppressor-cells-in-non-small-cell-lung-cancer/337513.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"G-MDSCs在非小细胞肺癌中主要通过哪些机制发挥免疫抑制作用？","Question",{"text":112,"@type":113},"G-MDSCs可通过表达精氨酸酶I（Arg-1）及活性氧（ROS）等机制抑制T细胞杀伤功能，重塑肿瘤免疫微环境并促进肿瘤进展。","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"G-MDSCs的水平与NSCLC患者的预后有什么关系？",{"text":117,"@type":113},"外周血及肺肿瘤组织中G-MDSCs富集程度与总生存期、不良分期及淋巴结转移密切相关。高水平G-MDSCs通常提示不良预后。",{"name":119,"@type":110,"acceptedAnswer":120},"G-MDSCs如何影响免疫治疗疗效？",{"text":121,"@type":113},"接受PD-L1相关免疫治疗的NSCLC患者外周血中，G-MDSCs可表现出更高的PD-L1表达水平，高水平G-MDSCs会抑制免疫治疗效果并降低生存率。",{"name":123,"@type":110,"acceptedAnswer":124},"文章如何概述G-MDSCs对T细胞功能的影响？",{"text":125,"@type":113},"文中指出G-MDSCs通过代谢相关途径抑制T细胞功能，主要涉及Arg-1产生与L-精氨酸消耗，进而影响T细胞受体信号传导及后续细胞免疫效应。","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},337513,1790271968,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":143,"language_code":63,"site_id":62,"html_lang":144,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":46,"preview_page_count":19,"preview_urls":149},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","中国肺癌杂志2 0 2 4年􀀱月第2 7卷第􀀱期 Chin J Lung Cancer, January 2 0 2 4 , Vol . 2 7, No. 􀀱 DOI: 􀀱0.3779/j.issn.􀀱009-34􀀱9.2023.􀀱06.28  \n粒细胞样髓源性抑制细胞在非小细胞肺癌中的研究进展  \n·65 ·  \n·综述 ·  \n杨朝丹 朱蕊 张煜婷 应莉莎 王佳敏 刘盼 苏丹  \n【摘要】粒细胞样髓源性抑制细胞（granulocytic myeloid-derived suppressor cells, G-MDSCs）是MDSCs的主要亚群之一，在多数癌症中广泛富集，通过表达精氨酸酶􀀱（arginase-􀀱, Arg- 􀀱)及活性氧（reactive oxygen species, ROS）等机制抑制淋巴T细胞杀伤功能，重塑肿瘤免疫微环境，促进肿瘤的发生发展。近年来，越来越多的研究发现G-MDSCs与非小细胞肺癌患者的预后和免疫治疗疗效具有显著相关性，使用特异性靶向G-MDSCs的募集、分化和功能的药物能够有效抑制肿瘤的进展。本文主要就G-MDSCs在非小细胞肺癌中的免疫抑制作用及其相关通路靶向药物的研究进展进行综述。  \n【关键词】 肺肿瘤；粒细胞样髓源性抑制细胞；免疫微环境；免疫治疗；靶向治疗  \nResearch Progress of Granulocytic Myeloid-derived Suppressor Cells in Non-small Cell Lung Cancer  \nChaodanYANG􀀱,2,3, Rui ZHU4, Yuting ZHANG5, LishaYING4, Jiamin WANG􀀱,2,3, Pan LIU4, Dan SU􀀱,4  \n1School of Molecular Medicine, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China; 2Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; 3University of Chinese Academy of Sciences, Beijing 100049, China; 4Department of Pathology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, China; 5Postgraduate Training Base Alliance of Wenzhou Medical University, Zhejiang Cancer Hospital, Hangzhou 310022, China  \nCorresponding author: Dan SU, E-mail: [sudan@zjcc.org.cn](sudan@zjcc.org.cn)  \n【Abstract】 Granulocytic myeloid-derived suppressor cells (G-MDSCs) are one of the main subgroups of MDSCs, which are widely enriched in most cancers. It can inhibit the killing function ofT-lymphocyte through the expression of arginase-􀀱 (Arg- 􀀱 ) and reactive oxygen species (ROS), reshape the tumor immune microenvironment, and promote the occurrence and development of tumors. In recent years, more and more studies have found that G-MDSCs are significantly correlated with the prognosis and immunotherapy efficacy of patients with non-small cell lung cancer, and the use of drugs specifically targeting the recruitment, differentiation and function of G-MDSCs can effectively inhibit tumor progression. This article reviews the immunosuppressive effect of G-MDSCs in non-small cell lung cancer and the progress of related pathway targeting drugs.  \n【Keywords】 Lung neoplasms; Granulocytic myeloid-derived suppressor cells; Immune microenvironment; Immunotherapy; Targeted therapy  \n【Copyright statement】 Copyright © 2024, Chinese Journal of Lung Cancer.  \nThis paper was supported by the grants from Major Science and Technology Project of Zhejiang Province of China (No.2020C03023)(toDanSU) and Medical Science and Technology Project of Zhejiang Province (No.2023RC006)(toPan LIU).  \n本文受浙江省重大科技专项（No.2020C03023）和浙江省医药卫生科技计划（No.2023RC006）资助  \n作者单位：3􀀱0024 杭州，国科大杭州高等研究院分子医学院（杨朝丹，王佳敏，苏丹）；20􀀱203上海，中国科学院上海药物研究所（杨朝丹，王佳敏）； 􀀱 0 0 0 4 9 北京， 中国科学院大学（杨朝丹，王佳敏）；3􀀱0022杭州，浙江省肿瘤医院病理科，中国科学院杭州医学研究所（朱蕊，应莉莎，刘盼，苏丹） ；3􀀱0022杭州，温州医科大学研究生培养基地，浙江省肿瘤医院（张煜婷） （通信作者：苏丹，E-mail: [sudan@zjcc.org.cn](sudan@zjcc.org.cn)）  \n肺癌是一种起源于肺部气管、支气管黏膜或腺体的恶性肿瘤。美国临床肿瘤杂志发布的2 0 2 0全球癌症统计[􀀱]显示，肺癌是男性第一高发的癌症类型，占总病例的􀀱4.3%，也是男性癌症相关死亡的第一大原因；在女性癌症患者中肺癌发病率排名第三，死亡人数占女性癌症死亡总数的􀀱3 .7%，仅次于乳腺癌，排名第二。肺癌患者中非小细胞肺癌（non-small cell lung cancer, NSCLC）患病人数  \n·66 · 中国肺癌杂志2 0 2 4年􀀱月第2 7卷第􀀱期 Chin J Lung Cancer, January 2 0 2 4 , Vol . 2 7, No. 􀀱  \n占整体肺癌患者的85%左右[2]。随着分子靶向治疗及免疫治疗的兴起，许多分子靶向药物和免疫治疗药物已经成功应用于NSCLC的临床治疗，例如表皮生长因子受体抑制剂、免疫检查点抑制剂等[3]。然而，多数分子靶向药物在治疗过程中易产生耐药性，患者可能出现疗效不佳、治疗周期延长和毒副作用增大等问题[4]。因此，寻找NSCLC 的新型分子治疗靶点并开发相应的抑制剂是当前亟需解决的重要问题。  \n近年来，研究人员对肿瘤微环境（tumor microenvironment, T ME）在肿瘤发生发展中的调控机制越来越重视。髓源性抑制细胞（myeloid-derived suppressor cells, MDSCs）在TME中发挥免疫抑制功能，其中粒细胞样MDSCs（granulocytic MDSCs, G-MDSCs）是MDSCs中最主要的细胞亚群，对NSCLC和其他多种恶性肿瘤的发生发展有重要影响[5]。因此，针对G-MDSCs相关通路的靶向治疗可能为NSCLC的精准治疗提供新机遇。  \n1 G-MDSCs的生成  \n根据细胞表型和基因表达谱的差异，MDS Cs主要分为粒细胞来源的G-MDS Cs和单核细胞来源的单核细胞样MDS Cs（mono cy tic MDSCs, M-MDS Cs）。 G-MDS Cs也被称作多核MDS Cs（polymorphonuclear MDS Cs , PM N-MDS Cs），它是中性粒细胞分化异常而产生的一种具有免疫抑制功能的G-MDS Cs，人类G-M D S C s在细胞表型上被定义为C D 􀀱 4 – CD􀀱􀀱b + CD3 3 + CD􀀱5 +/CD 6 6 b +，小鼠中G-MD","cbCaiirFf911cXGK","https://ap.wps.com/l/cbCaiirFf911cXGK","pdf",1225260,"Chinese","en","# 粒细胞样髓源性抑制细胞在非小细胞肺癌中的研究进展\n## 粒细胞样髓源性抑制细胞的生成\n## G-MDSCs促进NSCLC恶性进展的分子机制\n### 影响T细胞功能","[{\"question\":\"G-MDSCs在非小细胞肺癌中主要通过哪些机制发挥免疫抑制作用？\",\"answer\":\"G-MDSCs可通过表达精氨酸酶I（Arg-1）及活性氧（ROS）等机制抑制T细胞杀伤功能，重塑肿瘤免疫微环境并促进肿瘤进展。\"},{\"question\":\"G-MDSCs的水平与NSCLC患者的预后有什么关系？\",\"answer\":\"外周血及肺肿瘤组织中G-MDSCs富集程度与总生存期、不良分期及淋巴结转移密切相关。高水平G-MDSCs通常提示不良预后。\"},{\"question\":\"G-MDSCs如何影响免疫治疗疗效？\",\"answer\":\"接受PD-L1相关免疫治疗的NSCLC患者外周血中，G-MDSCs可表现出更高的PD-L1表达水平，高水平G-MDSCs会抑制免疫治疗效果并降低生存率。\"},{\"question\":\"文章如何概述G-MDSCs对T细胞功能的影响？\",\"answer\":\"文中指出G-MDSCs通过代谢相关途径抑制T细胞功能，主要涉及Arg-1产生与L-精氨酸消耗，进而影响T细胞受体信号传导及后续细胞免疫效应。\"}]","粒细胞样髓源性抑制细胞在非小细胞肺癌中的研究进展 | PDF",1790019382,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2439fad76846d9d4c3307e8b1b01f9e2.webp",983,1369,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73f040555cfee96a66b3cc0cbc9ab8f2.webp",982,1368,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc52251c7556467b9bca3e63d4a9e801.webp",981,1367,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a39da2ae54499247fd9561f0399ffddb.webp",980,1365]